Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development

Recently, the long-term use of sedative agents in the neonatal intensive care unit (NICU) has raised concerns about neurodevelopmental outcomes in exposed neonates. Midazolam (MDZ), a common neonatal sedative in the NICU, has been suggested to increase learning disturbances and cognitive impairment...

Full description

Bibliographic Details
Main Authors: Nghi M. Nguyen, Daniel Meyer, Luke Meyer, Subhash Chand, Sankarasubramanian Jagadesan, Maireen Miravite, Chittibabu Guda, Sowmya V. Yelamanchili, Gurudutt Pendyala
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/6/966
_version_ 1797612857110560768
author Nghi M. Nguyen
Daniel Meyer
Luke Meyer
Subhash Chand
Sankarasubramanian Jagadesan
Maireen Miravite
Chittibabu Guda
Sowmya V. Yelamanchili
Gurudutt Pendyala
author_facet Nghi M. Nguyen
Daniel Meyer
Luke Meyer
Subhash Chand
Sankarasubramanian Jagadesan
Maireen Miravite
Chittibabu Guda
Sowmya V. Yelamanchili
Gurudutt Pendyala
author_sort Nghi M. Nguyen
collection DOAJ
description Recently, the long-term use of sedative agents in the neonatal intensive care unit (NICU) has raised concerns about neurodevelopmental outcomes in exposed neonates. Midazolam (MDZ), a common neonatal sedative in the NICU, has been suggested to increase learning disturbances and cognitive impairment in children. However, molecular mechanisms contributing to such outcomes with long-term MDZ use during the early stages of life remain unclear. In this study, we for the first time elucidate the role of brain-derived extracellular vesicles (BDEVs), including mining the BDEV proteome post long-term MDZ exposure during early development. Employing our previously established rodent model system that mimics the exposure of MDZ in the NICU using an increasing dosage regimen, we isolated BDEVs from postnatal 21-days-old control and MDZ groups using a differential sucrose density gradient. BDEVs from the control and MDZ groups were then characterized using a ZetaView nanoparticle tracking analyzer and transmission electron microscopy analysis. Next, using RT-qPCR, we examined the expression of key ESCRT-related genes involved in EV biogenesis. Lastly, using quantitative mass spectrometry-based proteomics, we mined the BDEV protein cargo that revealed key differentially expressed proteins and associated molecular pathways to be altered post long-term MDZ exposure. Our study characterized the proteome in BDEV cargo from long-term MDZ exposure at early development. Importantly, we identified and validated the expression of YWHAH as a potential target for further characterization of its downstream mechanism and a potential biomarker for the early onset of neurodevelopment and neurodegenerative diseases. Overall, the present study demonstrated long-term exposure to MDZ at early development stages could influence BDEV protein cargo, which potentially impact neural functions and behavior at later stages of development.
first_indexed 2024-03-11T06:47:54Z
format Article
id doaj.art-af8dc9bc55304faaa55319481fe9cbcc
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T06:47:54Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-af8dc9bc55304faaa55319481fe9cbcc2023-11-17T10:14:25ZengMDPI AGCells2073-44092023-03-0112696610.3390/cells12060966Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early DevelopmentNghi M. Nguyen0Daniel Meyer1Luke Meyer2Subhash Chand3Sankarasubramanian Jagadesan4Maireen Miravite5Chittibabu Guda6Sowmya V. Yelamanchili7Gurudutt Pendyala8Department of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USADepartment of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USARecently, the long-term use of sedative agents in the neonatal intensive care unit (NICU) has raised concerns about neurodevelopmental outcomes in exposed neonates. Midazolam (MDZ), a common neonatal sedative in the NICU, has been suggested to increase learning disturbances and cognitive impairment in children. However, molecular mechanisms contributing to such outcomes with long-term MDZ use during the early stages of life remain unclear. In this study, we for the first time elucidate the role of brain-derived extracellular vesicles (BDEVs), including mining the BDEV proteome post long-term MDZ exposure during early development. Employing our previously established rodent model system that mimics the exposure of MDZ in the NICU using an increasing dosage regimen, we isolated BDEVs from postnatal 21-days-old control and MDZ groups using a differential sucrose density gradient. BDEVs from the control and MDZ groups were then characterized using a ZetaView nanoparticle tracking analyzer and transmission electron microscopy analysis. Next, using RT-qPCR, we examined the expression of key ESCRT-related genes involved in EV biogenesis. Lastly, using quantitative mass spectrometry-based proteomics, we mined the BDEV protein cargo that revealed key differentially expressed proteins and associated molecular pathways to be altered post long-term MDZ exposure. Our study characterized the proteome in BDEV cargo from long-term MDZ exposure at early development. Importantly, we identified and validated the expression of YWHAH as a potential target for further characterization of its downstream mechanism and a potential biomarker for the early onset of neurodevelopment and neurodegenerative diseases. Overall, the present study demonstrated long-term exposure to MDZ at early development stages could influence BDEV protein cargo, which potentially impact neural functions and behavior at later stages of development.https://www.mdpi.com/2073-4409/12/6/96614-3-3 etaMidazolamNICUextracellular vesiclesproteomicsneurodevelopment
spellingShingle Nghi M. Nguyen
Daniel Meyer
Luke Meyer
Subhash Chand
Sankarasubramanian Jagadesan
Maireen Miravite
Chittibabu Guda
Sowmya V. Yelamanchili
Gurudutt Pendyala
Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
Cells
14-3-3 eta
Midazolam
NICU
extracellular vesicles
proteomics
neurodevelopment
title Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_full Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_fullStr Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_full_unstemmed Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_short Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development
title_sort identification of ywhah as a novel brain derived extracellular vesicle marker post long term midazolam exposure during early development
topic 14-3-3 eta
Midazolam
NICU
extracellular vesicles
proteomics
neurodevelopment
url https://www.mdpi.com/2073-4409/12/6/966
work_keys_str_mv AT nghimnguyen identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT danielmeyer identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT lukemeyer identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT subhashchand identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT sankarasubramanianjagadesan identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT maireenmiravite identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT chittibabuguda identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT sowmyavyelamanchili identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment
AT guruduttpendyala identificationofywhahasanovelbrainderivedextracellularvesiclemarkerpostlongtermmidazolamexposureduringearlydevelopment